ANTIGENICS INC

Company

AGENUS INC

Filed

April 24, 2000

Period of Report

May 18, 2000

Accession Number

0000950135-00-002293

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →